{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T21:37:35Z","timestamp":1771969055981,"version":"3.50.1"},"reference-count":13,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2021,8,30]]},"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1183\/13993003.02124-2021","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T14:49:00Z","timestamp":1632494940000},"page":"2102124","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Bedaquiline can act as core drug in a standardised treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis"],"prefix":"10.1183","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-1484","authenticated-orcid":false,"given":"Tom","family":"Decroo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kya Jai Maug","family":"Aung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Anwar","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mourad","family":"Gumusboga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimer","family":"Ortuno-Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1017-4675","authenticated-orcid":false,"given":"Bouke Catherine","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armand","family":"Van Deun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"2024102102395554000_59.3.2102124.1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.14.0100"},{"key":"2024102102395554000_59.3.2102124.2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.5588\/ijtld.19.0053","article-title":"Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB","volume":"23","author":"Van Deun","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102102395554000_59.3.2102124.3","doi-asserted-by":"crossref","first-page":"e0238016","DOI":"10.1371\/journal.pone.0238016","article-title":"Injectables\u2019 key role in rifampicin-resistant tuberculosis shorter treatment regimens outcomes","volume":"15","author":"Decroo","year":"2020","journal-title":"PLoS ONE"},{"key":"2024102102395554000_59.3.2102124.4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pulmoe.2021.02.006","article-title":"Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: results from a large global cohort","volume":"27","author":"Koirala","year":"2021","journal-title":"Pulmonology"},{"key":"2024102102395554000_59.3.2102124.5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0041-3879(89)90035-4","article-title":"Slide culture sensitivity tests","volume":"70","author":"Dickinson","year":"1989","journal-title":"Tubercle"},{"key":"2024102102395554000_59.3.2102124.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00223-2017"},{"key":"2024102102395554000_59.3.2102124.7","unstructured":"World Health Organization . WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment \u2013 Drug-Resistant Tuberculosis Treatment. Geneva, World Health Organization, 2020."},{"key":"2024102102395554000_59.3.2102124.8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5588\/ijtld.17.0660","article-title":"Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs","volume":"22","author":"Van Deun","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102102395554000_59.3.2102124.9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijid.2020.08.042","article-title":"Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen","volume":"100","author":"Lempens","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2024102102395554000_59.3.2102124.10","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0166"},{"key":"2024102102395554000_59.3.2102124.11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jac\/dkaa489","article-title":"Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?","volume":"76","author":"Tahseen","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2024102102395554000_59.3.2102124.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02383-2019"},{"key":"2024102102395554000_59.3.2102124.13","doi-asserted-by":"crossref","first-page":"2002250","DOI":"10.1183\/13993003.02250-2020","article-title":"High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss","volume":"57","author":"Souleymane","year":"2020","journal-title":"Eur Respir J"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.02124-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:47:40Z","timestamp":1740376060000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.02124-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,24]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1183\/13993003.02124-2021"],"URL":"https:\/\/doi.org\/10.1183\/13993003.02124-2021","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}